Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mometasone furoate/formoterol versus mometasone furoate, formoterol, and placebo in persistent asthma
2006-001578-25Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Sep 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of mometasone and formoterol in persistent asthma (4 arms), sponsored by Merck & Co. Primary endpoint: AUC (0-12 hr) of change from baseline to Week 12 in FEV1. Started Sep 2006; status: completed.
02
Drugs
mometasoneformoterol
03
Conditions
persistent asthma
Beyond the preview
Go deeper on 2006-001578-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001578-25.